Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NeuroSearch A/S

+ Add to Watchlist

NEUR:DC

3.2600 DKK 0.1000 3.16%

As of 10:59:59 ET on 05/22/2015.

Snapshot for NeuroSearch A/S (NEUR)

Open: 3.2000 Day's Range: 3.1600 - 3.2600 Volume: 40,208
Previous Close: 3.1600 52wk Range: 2.4500 - 3.6200 1-Yr Rtn: -9.19%

Stock Chart for NEUR

No chart data available.
  • NEUR:DC 3.2600
  • 1D
  • 1M
  • 1Y
3.1600
Interactive NEUR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NEUR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. KFX -
Earnings Per Share (DKK) (ttm) -0.5590
Est. EPS (DKK) (12/2015) -
Est. PEG Ratio -
Market Cap (M DKK) 80.05
Shares Outstanding (M) 24.55
30 Day Average Volume 37,892
Price/Book (mrq) 0.9003
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NEUR

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NEUR

NeuroSearch A/S is a bio-pharmaceutical company. The Company researches and develops compounds for the treatment for diseases of the central nervous system such as Huntington's disease, attention deficit disorder, schizophrenia, dyskinesias, cognitive dysfunctions, depression and anxiety, and social anxiety disorder. NeuroSearch also researches treatments for obesity.

Rene SchneiderCEO/CFOFinn Eggert SorensenExec VP/Chief Business Officer
Karin GarreExec VP/Chief Development OfficerMorten Henrik NielsenDir:IT
More Company Profile & Key Executives for NEUR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil